Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.
Nora MöhnFiras SakerViktoria BondaGesine RespondekMarcus BachmannMatthias StollMike P WattjesMartin StangelThomas SkripuletzPublished in: Journal of neurology (2020)